000057924 001__ 57924
000057924 005__ 20180911133101.0
000057924 0247_ $$2doi$$a10.1155/2013/849349
000057924 0248_ $$2sideral$$a82910
000057924 037__ $$aART-2013-82910
000057924 041__ $$aeng
000057924 100__ $$aTorrón, C.
000057924 245__ $$aUse of a new ocular insert versus conventional mydriasis in cataract surgery
000057924 260__ $$c2013
000057924 5060_ $$aAccess copy available to the general public$$fUnrestricted
000057924 5203_ $$aBackground. To compare the efficacy and safety of a new ocular insert versus conventional mydriasis in cataract surgery. Methods. We selected 70 patients undergoing cataract surgery. Thirty five patients (Group 1) received instillation of mydriatic drops (tropicamide 1%, phenylephrine 10%, and cyclopentolate 1%) prior to surgery, and 35 patients (Group 2) had a Mydriasert insert (Théa Pharma) (0.28¿mg of tropicamide and 5.4¿mg of phenylephrine hydrochloride) placed in the inferior fornix. Pupil size before and after surgery, blood pressure, and heart rate were measured. Results. Before surgery, pupil diameter was ¿mm in Group 1 and in Group 2 ( ). Twenty four hours after surgery, pupil diameter was ¿mm in Group 1 and in Group 2 ( ). There were no statistically significant differences in blood pressure or heart rate between groups. Conclusions. The effect of the Mydriasert insert was similar to conventional mydriatic agents. Pupil size was restored to normal faster when using the Mydriasert insert compared with conventional mydriatic agents for pupil dilation.
000057924 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000057924 590__ $$a0.0$$b2013
000057924 591__ $$aMEDICINE, RESEARCH & EXPERIMENTAL
000057924 591__ $$aBIOTECHNOLOGY & APPLIED MICROBIOLOGY
000057924 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000057924 700__ $$aCalvo, P.
000057924 700__ $$0(orcid)0000-0001-6664-6275$$aRuiz-Moreno, O.$$uUniversidad de Zaragoza
000057924 700__ $$aLeciñena, J.
000057924 700__ $$aPérez-Iñigo, A.
000057924 7102_ $$11004$$2646$$aUniversidad de Zaragoza$$bDpto. Cirugía,Ginecol.Obstetr.$$cÁrea Oftalmología
000057924 773__ $$g2013 (2013), 849349 [4 pp]$$pBioMed res. int.$$tBioMed Research International$$x2314-6133
000057924 8564_ $$s1211398$$uhttps://zaguan.unizar.es/record/57924/files/texto_completo.pdf$$yVersión publicada
000057924 8564_ $$s95753$$uhttps://zaguan.unizar.es/record/57924/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000057924 909CO $$ooai:zaguan.unizar.es:57924$$particulos$$pdriver
000057924 951__ $$a2018-09-11-13:27:53
000057924 980__ $$aARTICLE